Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06391788
Other study ID # 2023-ZX013
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 31, 2023
Est. completion date March 31, 2025

Study information

Verified date April 2024
Source China National Center for Cardiovascular Diseases
Contact Xin Wang
Phone 13901036490
Email fuwaiwangxin@188.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This single-center, prospective, open-label, randomized, controlled clinical trial is designed to assess the efficacy and safety of the Thoracoscopic Morrow procedure in the treatment of hypertrophic obstructive cardiomyopathy. The primary objectives include investigating: Question 1: The efficacy and safety of two surgical modalities in patients presenting with left ventricular outflow tract obstruction and mid-left ventricular hypertrophy. Question 2: The impact of the two surgical procedures on hemodynamics in patients with left ventricular outflow tract obstruction, mid-left ventricular obstruction, and in individuals with or without organic valvular lesions. Question 3: The effects of the two surgical procedures on exercise capacity, quality of life, and long-term prognosis among patients with left ventricular outflow tract obstruction and central left ventricular obstruction, both with and without valvular lesions. Participants will be stratified into two groups. The experimental group will undergo thoracoscopic Morrow surgery, while the control group will undergo median open modified enlarged Morrow surgery.


Description:

This study is a single-center, prospective, open-label, randomized, controlled trial designed to investigate the therapeutic value of thoracoscopic Morrow procedure in patients with hypertrophic obstructive cardiomyopathy (HOCM). The study focuses on HOCM patients, with the modified extended Morrow procedure via median sternotomy considered as the 'gold standard treatment' in the control group. The objective is to explore the efficacy of the thoracoscopic Morrow procedure in improving exercise tolerance in HOCM patients, assess the short-term and long-term effectiveness, safety, as well as changes in cardiac function, cardiac structure, and myocardial fibrosis levels associated with thoracoscopic Morrow procedure in treating obstructive HOCM.


Recruitment information / eligibility

Status Recruiting
Enrollment 132
Est. completion date March 31, 2025
Est. primary completion date February 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - diagnosed with hypertrophic cardiomyopathy (HCM); - age =18 years old; - presence of left ventricular outflow tract/mid-ventricular obstruction, with a resting left ventricular outflow tract pressure gradient/left ventricular cavity pressure gradient =50 mmHg; significant symptoms persist despite optimal medical therapy, and surgical evaluation indicates the need for intervention; - left ventricular ejection fraction (LVEF) =55%; - signed informed consent, willing and able to return to the hospital for follow-up. Exclusion Criteria: - previously underwent septal reduction therapy (including surgical or interventional procedures); - received or planning to receive an implantable cardioverter-defibrillator (ICD) in the past 3 months; - individuals with concomitant conditions requiring simultaneous surgical intervention; - New York Heart Association (NYHA) functional class IV; - unwilling to undergo surgical treatment; - pregnant or lactating or planning pregnancy; - previously participated in other clinical trials before enrollment; - individuals with concurrent diseases with an expected lifespan of less than 1 year.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
thoracoscopic Morrow surgery
minimally invasive trans-mitral Morrow septal myectomy
modified Morrow surgery
median open modified enlarged Morrow septal myectomy

Locations

Country Name City State
China Fuwai Hospital, National Centre for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing

Sponsors (1)

Lead Sponsor Collaborator
China National Center for Cardiovascular Diseases

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Left ventricular outflow tract gradient variability Change in Left ventricular outflow tract gradient pre- and post- intervention 6 months,9 months and 12 months
Secondary 6-minute walk distance A measure used to assess the functional exercise capacity of individuals. It is determined by the distance a person can walk in 6 minutes on a flat, hard surface. 6 months,9 months and 12 months
Secondary New York Heart Association Functional Classification of Heart Failure A system used to categorize the severity of heart failure based on the functional limitations of individuals. 6 months,9 months and 12 months
Secondary Marker of myocardial injury To assay the concentration of proteins(cardiac troponin T, cardiac troponin I)associated with myocardial injury. 6 months,9 months and 12 months
Secondary Kansas City Cardiomyopathy Questionnaire - Clinical Summary Score A disease-specific health status measure designed to assess the impact of heart failure on patients' quality of life. 6 months,9 months and 12 months
Secondary Echocardiographic indicator Left ventricular ejection fraction assessed by echocardiography. 6 months,9 months and 12 months
Secondary Cardiac magnetic resonance indicator The left ventricular mass index was assessed using cardiac magnetic resonance imaging. 6 months,9 months and 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06202053 - An Observational Study on the Quality of Life After Precise Lung Resection Through the Periareolar Incision
Not yet recruiting NCT06050161 - Evaluating Artisential Laparoscopic Instruments in Gynecologic Surgery N/A
Active, not recruiting NCT04568993 - The TriggerHappy Trial N/A
Recruiting NCT03427840 - Superior Hypogastric Plexus Blockade in Laparoscopic Hysterectomy
Recruiting NCT04211948 - Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer N/A
Completed NCT02505880 - Hypnosis Versus General Anesthesia in Pediatric Surgery: Clinical and Medico-economic Interests N/A
Completed NCT04231903 - Myocardial Protection in Minimally Invasive Mitral Valve Surgery
Recruiting NCT04370496 - Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION) N/A
Completed NCT04206696 - Learning Curve for Minimally Invasive Oesophagectomy and Contrast With Open Procedure
Recruiting NCT04718272 - Safety and Feasibility of the Application of Thoracic Puncture Tube After Pulmonary Lobectomy N/A
Recruiting NCT05971875 - RCT on 3 Types of Hysterectomy N/A
Completed NCT06289816 - Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes
Not yet recruiting NCT05173467 - Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor N/A
Recruiting NCT06466902 - Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
Completed NCT02621710 - Goal Achievement and Patient Satisfaction in Benign Hysterectomy N/A
Completed NCT03642743 - Patient Satisfaction With Postoperative Follow up After Minimally Invasive Hysterectomy N/A
Recruiting NCT05019404 - Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy N/A
Recruiting NCT02085031 - Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer Phase 2
Completed NCT06385210 - Barriers to Routine Surgical Video Recording N/A